Find similar content

Source channel @githubtrending · Post #14902 · Jul 3

#go#tailscale#tailscale_control_server#tailscale_server#wireguard Headscale is an open-source, self-hosted alternative to the Tailscale control server, letting you create your own private VPN network using Wireguard technology. It supports key Tailscale features like node registration, DNS, file sharing (Taildrop), access control lists (ACLs), and more, making it ideal for personal or small group use. By running Headscale yourself, you gain full control over your network without relying on Tailscale’s servers, enhancing privacy and customization. You can manage access precisely with ACLs, tag devices for group policies, and use modern VPN benefits like NAT traversal and secure connections between your devices[1][3][5]. This helps you securely connect and control your devices in a private network tailored to your needs. https://github.com/juanfont/headscale

Hashtags

#go #tailscale #tailscale_control_server #tailscale_server #wireguard

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment